2021
DOI: 10.1111/hiv.13168
|View full text |Cite
|
Sign up to set email alerts
|

No increased risk of Kaposi sarcoma relapse in patients with controlled HIV‐1 infection after switching protease inhibitor‐based antiretroviral therapy

Abstract: The members of the 'And The Dat'AIDS study group' are given in the Appendix.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 18 publications
0
1
0
Order By: Relevance
“…In cohorts of KS patients that aimed to identify predictive factors of KS remission, response rate was not associated with NNRTI-based, PI-based, or boosted-PI based regimen [63,64]. Furthermore, an analysis of the prospectively collected Dat'AIDS database focusing on PLHIV with history of KS and controlled HIV replication, switching from a PI-based to a PI-free regimen was not associated with an increased risk of KS relapse [65].…”
Section: Role Of Protease Inhibitors For Treatmentmentioning
confidence: 92%
“…In cohorts of KS patients that aimed to identify predictive factors of KS remission, response rate was not associated with NNRTI-based, PI-based, or boosted-PI based regimen [63,64]. Furthermore, an analysis of the prospectively collected Dat'AIDS database focusing on PLHIV with history of KS and controlled HIV replication, switching from a PI-based to a PI-free regimen was not associated with an increased risk of KS relapse [65].…”
Section: Role Of Protease Inhibitors For Treatmentmentioning
confidence: 92%